Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Januvia (sitagliptin) and Victoza (liraglutide) are both medications used to treat Type 2 diabetes, but they work in different ways and have different forms of administration. Januvia is a dipeptidyl peptidase 4 (DPP-4) inhibitor taken orally once a day, while Victoza is a Glucagon-like peptide-1 (GLP-1) agonist that you inject under the skin daily. Januvia helps lower blood sugar by blocking the DPP-4 protein, which allows insulin to stay in your body longer. On the other hand, Victoza works by telling your body to release more insulin, stopping the release of more sugar, and slowing down digestion. Victoza can also help reduce the risk of heart-related problems in adults with Type 2 diabetes and heart disease, a benefit not mentioned for Januvia. Common side effects of Januvia include runny nose and sore throat, whereas Victoza often causes nausea and diarrhea. Additionally, Januvia does not typically affect body weight, while Victoza may help with weight loss.
Januvia (sitagliptin)
Victoza (liraglutide)
Januvia (sitagliptin)
Victoza (liraglutide)
Summary of Januvia vs. Victoza
Summary for DDP-4 inhibitor
Prescription only
Januvia (sitagliptin) is a prescription medication that helps lower blood sugar in adults with Type 2 diabetes. It works best when you also follow a balanced diet and exercise regularly. It belongs to the drug class called dipeptidyl peptidase-4 (DPP-4) inhibitors, or gliptins. Januvia (sitagliptin) comes as a tablet you take by mouth once a day. Side effects include stuffy or runny nose and headache. Januvia (sitagliptin) is a brand-name medication only; the generic version isn't available yet.
Summary for GLP-1 agonist
Prescription only
Victoza (liraglutide) is a medication that's injected once a day. It helps lower blood sugar levels in people 10 years and older with Type 2 diabetes when used with a nutritious diet and regular exercise. It can also help lower the risk of heart-related problems in adults with Type 2 diabetes and heart disease. Victoza (liraglutide) belongs to the drug class called GLP-1 agonists. The medication comes as single-dose prefilled pens and is injected under the skin. It can cause side effects like nausea, vomiting, diarrhea, and constipation. Victoza (liraglutide) is available as both a brand-name and generic medication.